Nrgene Technologies (Israel) Today
| NRGN Stock | ILA 392.90 47.90 13.88% |
Performance13 of 100
| Odds Of DistressLess than 20
|
Nrgene Technologies is trading at 392.90 as of the 26th of November 2024, a 13.88 percent increase since the beginning of the trading day. The stock's open price was 345.0. Nrgene Technologies has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. Equity ratings for Nrgene Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of July 2023 and ending today, the 26th of November 2024. Click here to learn more.
Energin .R Technologies 2009 LTD., a genomic big data company, provides computational tools to seed and food companies worldwide. The company was founded in 2009 and is headquartered in Ness Ziona, Israel. ENERGIN R operates under SoftwareApplication classification in Israel and is traded on Tel Aviv Stock Exchange. The company has 12.52 M outstanding shares. More on Nrgene Technologies
Moving together with Nrgene Stock
Moving against Nrgene Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Nrgene Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Nrgene Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Nrgene Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Software—Application, Technology, Computing (View all Sectors) |
Nrgene Technologies (NRGN) is traded on Tel Aviv Stock Exchange in Israel and employs 55 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 67.62 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nrgene Technologies's market, we take the total number of its shares issued and multiply it by Nrgene Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nrgene Technologies operates under Technology sector and is part of Software—Application industry. The entity has 12.52 M outstanding shares.
Nrgene Technologies has accumulated about 1.48 M in cash with (1.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.
Check Nrgene Technologies Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Nrgene Technologies is 67.62 Million. Nrgene Technologies holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Nrgene Ownership Details
Nrgene Technologies Risk Profiles
Although Nrgene Technologies' alpha and beta are two of the key measurements used to evaluate Nrgene Technologies' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.09 | |||
| Semi Deviation | 2.78 | |||
| Standard Deviation | 3.46 | |||
| Variance | 11.97 |
Nrgene Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nrgene Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Nrgene Technologies Corporate Management
Elected by the shareholders, the Nrgene Technologies' board of directors comprises two types of representatives: Nrgene Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nrgene. The board's role is to monitor Nrgene Technologies' management team and ensure that shareholders' interests are well served. Nrgene Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nrgene Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Radolsky | Accountant | Profile | |
| Kobi Baruch | Chief Officer | Profile | |
| Ehud Belder | Chief Officer | Profile | |
| Noam Barkai | VP RD | Profile | |
| Yana Voldman | Marketing Director | Profile | |
| Gil Ronen | CEO CoFounder | Profile | |
| Yaakov Baruch | VP Analysis | Profile |
Other Information on Investing in Nrgene Stock
Nrgene Technologies financial ratios help investors to determine whether Nrgene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nrgene with respect to the benefits of owning Nrgene Technologies security.